BNT162b2 mRNA Covid-19 Vaccine in AYA with cancer: a monocentric experience

COVID-19 infection in pediatric cancer patients is severe or critical in 20% of the patients. It can therefore directly affect pediatric cancer patients and/or their care. We aimed at evaluating the safety and efficacy of BNT162b2 mRNA Covid-19 vaccine in AYA with solid tumor.

Source: European Journal of Cancer - June 23, 2021 Category: Cancer & Oncology Authors: Gabriel Revon-Riviere, Laetitia Ninove, Victoria Min, Ang élique Rome, Carole Coze, Arnauld Verschuur, Xavier de Lamballerie, Nicolas André Tags: Original Research Source Type: research